Form:	PCA3 Index Biopsy v2.0

CDE ID	CDE Description
* 421	EDRN Participant ID (Go To: 423)
* 423	EDRN Protocol ID (Go To: 422)
* 422	EDRN Site ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 844)
* 844	Date pathology report completed (MM/DD/YYYY): (Go To: 839)
839	ID number of local pathology report: (Go To: 1595)
* 1595	Inflammation present? (Go To: 1598)
	Permissible Values (value): No (0)
	Yes (1)
1598	Atrophy? (Go To: 1586)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
* 1586	Presence of prostate adenocarcinoma: (Go To: 2158)
	Permissible Values (value): Malignancy absent (1)
	Malignancy present (2)
* 2158	Number of specimens: (Go To: 2159)
* 2159	Specimen line number or identifier (system-generated): (Go To: 2709)
2709	Specimen identifier: (Go To: 2160)
* 2160	Tissue position (laterality): (Go To: 2211)
	Permissible Values (value): Right (1)
	Left (2)
	Unknown/refused (99)
2211	Tissue position (zone): (Go To: 2213)
	Permissible Values (value): Transition Zone (TZ) (1)
	Seminal vesicle (2)
	Anterior zone (3)
	Peripheral zone (4)
	Unknown (99)
2213	Tissue position (regionality): (Go To: 2212)
	Permissible Values (value): Apex (A) (1)
	Middle (M) (2)
	Base (B) (3)
	Unknown (99)
2212	Tissue position (position within region): (Go To: 2712)
	Permissible Values (value): Lateral (lat) (1)
	Medial (med) (2)
	Unknown (99)
* 2712	Specimen status (normal or abnormal): (Go To: 1097)
	Permissible Values (value): Normal (1)
	Positive for malignancy (3) (Go To: 1589)
	Abnormal but negative for malignancy (4) (Go To: 984)
	Unknown (99)
* 1589	Primary Gleason grade: (Go To: 1590)
* 1590	Secondary Gleason grade: (Go To: 1696)
1696	Tertiary Gleason Pattern: (Go To: 1697)
* 1697	Overall Gleason Score: (Go To: 2737)
* 2737	Histological type (prostate): (Go To: 2713)
	Permissible Values (value): Adenocarcinoma (4) (Go To: 2738)
	Sarcoma cell carcinoma (5)
	Squamous cell carcinoma (6)
	Transitional cell carcinoma (7)
	Unknown (99)
2738	Histological subtype: (check all that apply) (Go To: 2713)
	Permissible Values (value): Ductal (4)
	Mucinous (13)
	Neuroendocrine (15)
	Small cell carcinoma (19)
	Unknown (99)
* 2713	Method used to record quantity of cancer in specimen: (Go To: 984)
	Permissible Values (value): Percent cancer (1) (Go To: 2210)
	Length of cancer & length of specimen (2) (Go To: 2208)
* 2210	Percent of cancer in tissue: (Go To: 2838)
* 2838	Notation for percent cancer value: (Go To: 984)
	Permissible Values (value): < less than (1)
	No notation (10)
	Other, specify: (97) (Go To: 2839)
* 2839	Notation for percent cancer value (Other specify): (Go To: 984)
* 2208	Length of cancer in tissue specimen (mm): (Go To: 2209)
* 2209	Length of tissue specimen (mm): (Go To: 984)
* 984	High grade prostatic intraepithelial neoplasia (PIN)? (Go To: 1596)
	Permissible Values (value): No (0)
	Yes (1)
* 1596	Atypical small acinar proliferation (ASAP)? (Go To: 1597)
	Permissible Values (value): No (0)
	Yes (1)
* 1597	Atypia/Suspicious? (Go To: 1591)
	Permissible Values (value): No (0)
	Yes (1)
	Unknown (99)
1591	Perineural invasion: (Go To: 1097)
	Permissible Values (value): Present (1)
	Absent (2)
	Unknown (99)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)